30 Stocks Moving In Tuesday's Mid-Day Session

Gainers

• Asure Software, Inc. ASUR climbed 25.4% to $8.50 after the company announced it will sell its Workspace Management business to FM:Systems in an asset and equity transaction valued at $120 million.
• Neurotrope, Inc. NTRP shares rose 23% to $0.8725 after the company announced it would review a strategic alternatives to maximize shareholders value.
• NIO Inc. NIO shares rose 11.3% to $1.72 in pre-market trading after the company reported Q3 vehicle sales up 35% from Q2.
• Hawaiian Holdings, Inc. HA gained 7.1% to $27.01. Hawaiian Holdings reported a 3% rise in total September traffic.
• Allegiance Bancshares, Inc. ABTX climbed 7% to $33.84. Allegiance Bancshares will replace Monotype Imaging Holdings in the S&P SmallCap 600 effective prior to the open of trading on October 11.
• Overstock.com, Inc. OSTK jumped 5.6% to $11.85.
• DRDGOLD Limited DRD rose 4.9% to $4.96.
• Centrais Eletricas Brasileiras S.A. – Eletrobras EBR shares gained 4.5% to $9.08.
• Nordic American Tankers Limited NAT gained 4.3% to $3.2123.

Check out these big penny stock gainers and losers

Losers

• QIAGEN N.V. QGEN shares dipped 21.4% to $25.20. Qiagen announced preliminary third-quarter sales, expecting sales growth of about 3% at constant exchange rates, lower than its earlier expectations for 4-5% growth, citing significantly weaker-than-expected developments in China. The company expects adjusted EPS within its outlook of 35-36 cents in constant exchange rate. Separately, the company announced a 15-year partnership with Illumina to broaden the availability and use of NGS-based in-vitro diagnostic kits, including companion diagnostics, for patient management. The company also said its Chairman and CEO Peer Schatz has decided to resign from the positions, although he will serve as Special Advisor to the Supervisory Board.
• Puma Biotechnology, Inc. PBYI fell 18.2% to $8.23. Goldman Sachs downgraded Puma Biotechnology from Neutral to Sell and lowered the price target from $24 to $8.
• DASAN Zhone Solutions, Inc. DZSI dropped 17.2% to $7.97 after the company reported weak preliminary sales results for its third quarter.
• AZZ Inc. AZZ dipped 15.1% to $36.50. AZZ is rescheduling Q2 financial results.
• SRAX, Inc. SRAX shares tumbled 11.8% to $2.1001.
• Clovis Oncology, Inc. CLVS dropped 11.1% to $3.2001. Goldman Sachs maintained Clovis Oncology with a Sell and lowered the price target from $13 to $3.
• electroCore, Inc. ECOR shares declined 10.9% to $2.28.
• Ambarella, Inc. AMBA fell 10.1% to $51.48 after its customer, Hangzhou Hikvision, was put on a blacklist by the Trump administration.
• Tetraphase Pharmaceuticals, Inc. TTPH shares declined 10.1% to $3.55.
• comScore, Inc. SCOR dropped 9.9% to $2.00.
• Jumia Technologies AG JMIA dipped 9.8% to $7.54.
• SmileDirectClub, Inc. SDC dropped 9.8% to $12.17.
• Aptose Biosciences Inc. APTO shares fell 9.5% to $1.8999.
• Viveve Medical, Inc. VIVE shares fell 9.3% to $3.4453.
• Syndax Pharmaceuticals, Inc. SNDX dipped 9% to $6.22.
• EZCORP, Inc. EZPW dropped 8.9% to $5.64.
• FTS International, Inc. FTSI shares declined 8.7% to $1.8450.
• Conduent Incorporated CNDT shares dropped 8.7% to $5.30.
• Nektar Therapeutics NKTR shares fell 8.5% to $17.09 after Goldman Sachs downgraded the company's stock from Buy to Sell and lowered the price target from $54 to $16.
• Just Energy Group Inc. JE fell 7.8% to $2.13. Canaccord Genuity downgraded Just Energy Group from Buy to Hold.
• DBV Technologies S.A. DBVT shares fell 7.8% to $7.58 after declining 7.74% on Monday.